Endothelin-1 is associated with mortality that can be attenuated with high intensity statin therapy in patients with stable coronary artery disease

BACKGROUND: All coronary artery disease (CAD) patients do not benefit equally of secondary prevention. Individualized intensity of drug therapy is currently implemented in guidelines for CAD and diabetes. Novel biomarkers are needed to identify patient subgroups potentially benefitting from individu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ruizhu, Junttila, Juhani, Piuhola, Jarkko, Lepojärvi, E. Samuli, Magga, Johanna, Kiviniemi, Antti M., Perkiömäki, Juha, Huikuri, Heikki, Ukkola, Olavi, Tulppo, Mikko, Kerkelä, Risto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287654/
https://www.ncbi.nlm.nih.gov/pubmed/37349571
http://dx.doi.org/10.1038/s43856-023-00322-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287654/
https://www.ncbi.nlm.nih.gov/pubmed/37349571
http://dx.doi.org/10.1038/s43856-023-00322-9

Ejemplares similares